Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
Prince Albert II of Monaco has appointed Christophe Mirmand as the new Minister of State on the 3rd of July, following Philippe Mettoux's recent withd...
Read More
More than 100 flights departing from and arriving at Nice airport today have been cancelled due to a nationwide strike by French air traffic controlle...
Read More
Due to an ozone pollution spike, only vehicles with Crit’Air green, 1, or 2 stickers can drive in Marseille's Low Emissions Zone (ZFE) on Wednesday, t...
Read More
Four departments in central France remain on a rare red heatwave alert today.
Read More
This first summer holiday weekend will see very heavy traffic across the VINCI Autoroutes network, especially in the Rhône Valley, towards the Atlanti...
Read More
